Male-biased gastrointestinal parasitism in a nearly monomorphic mountain ungulate

Background: Pyrenean chamois (Rupicapra pyrenaica pyrenaica) is a nearly monomorphic mountain ungulate with an unbiased sex-specific overwinter adult survival. Few differences in gastrointestinal parasitism have been reported by coprology as yet. This study aims to assess diversity, prevalence, intensity of infection and aggregation of gastrointestinal nematodes in male and female adult chamois. We expect no differences in the parasite infection rates between sexes. Findings: Gastrointestinal tracts of 28 harvested Pyrenean chamois in the Catalan Pyrenees (autumn 2012 and 2013) were necropsied and sexual differences in the diversity and structure of parasite community, prevalence, intensity of infection, and richness were investigated. We found 25 helminth species belonging to 13 different genera. Conclusions: Contrary to our expectations, male chamois showed different parasite communities, higher prevalence, intensity of infection and richness than females. Such sexual differences were clear irrespective of age of individuals. Hence, male chamois must cope with a more diverse and abundant parasite community than females, without apparent biological cost. Further research will be required to confirm this hypothesis

Gastrointestinal nematodes and dietary fibre: Two factors to consider when using FN for wildlife nutrition monitoring

Faecal nitrogen (FN) – the combination of metabolic nitrogen and residual food nitrogen – has been used as a proxy for diet quality in wild and domestic ruminants for over half a century. However, a common misconception in some of these studies is that FN is a direct proxy for dietary N, in spite of experimental evidence that links FN to general diet digestibility. Additionally, gastrointestinal nematodes (GIN) can alter N metabolism and increase FN by various mechanisms. To clarify the role of dietary N, fibre and GIN as a factor in FN excretion, 10 naturally parasitised sheep were fed two different isocaloric diets (LPF: low-protein, low-fibre; HPF: high-protein, high-fibre). One month after these diets began, a single anthelmintic treatment was applied to remove GIN, after which the sheep were kept on the same diet for an additional 2 weeks. Throughout the experiment, individual faecal samples were obtained to estimate both FN and GIN intensity (using faecal egg counts, FEC). In addition, two blood samples were taken before and after deworming to measure serum total protein concentrations (TP) as a proxy for protein absorption. In spite of the difference in dietary protein, FN was higher on an LPF diet, supporting the overall digestibility concept. The influence of GIN on FN was later revealed by the anthelmintic treatment, which led to a decrease of FEC and FN in both dietary groups. Serum total protein showed a slight but non-significant increase in both groups after the anthelmintic treatment. Our study supports not only the concept that FN is a proxy for diet digestibility, and not directly for dietary N, but also that gastrointestinal nematodes limit its use as a proxy for diet quality in ruminants, especially under high parasite loads (e.g.,1000 faecal eggs per gram of faeces). Such limitations should be considered before using FN for wildlife nutrition monitoring. Some recommendations are given to avoid misinterpretations

Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

Objectives: This study aimed to assess the real use of cefazolin for methicillin-susceptible Staphylococcus aureus (MSSA) infective endocarditis (IE) in the Spanish National Endocarditis Database (GAMES) and to compare it with antistaphylococcal penicillin (ASP). Methods: Prospective cohort study with retrospective analysis of a cohort of MSSA IE treated with cloxacillin and/or cefazolin. Outcomes assessed were relapse; intra-hospital, overall, and endocarditis-related mortality; and adverse events. Risk of renal toxicity with each treatment was evaluated separately. Results: We included 631 IE episodes caused by MSSA treated with cloxacillin and/or cefazolin. Antibiotic treatment was cloxacillin, cefazolin, or both in 537 (85%), 57 (9%), and 37 (6%) episodes, respectively. Patients treated with cefazolin had significantly higher rates of comorbidities (median Charlson Index 7, P <0.01) and previous renal failure (57.9%, P <0.01). Patients treated with cloxacillin presented higher rates of septic shock (25%, P = 0.033) and new-onset or worsening renal failure (47.3%, P = 0.024) with significantly higher rates of in-hospital mortality (38.5%, P = 0.017). One-year IE-related mortality and rate of relapses were similar between treatment groups. None of the treatments were identified as risk or protective factors. Conclusion: Our results suggest that cefazolin is a valuable option for the treatment of MSSA IE, without differences in 1-year mortality or relapses compared with cloxacillin, and might be considered equally effective